Desonide

Generic Name: Desonide

Brand Names: Desonate, Desowen, Desrx, Lokara, Tridesilon, Verdeso

Drug Type: Small Molecule

Chemical Formula: C_₂₄H_₃₂O_₆

CAS Number: 638-94-8

Unique Ingredient Identifier: J280872D1O

Background: A nonfluorinated corticosteroid anti-inflammatory agent used topically for dermatoses.

Indication: For the relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatose.

Associated Conditions: Dermatosis, Ocular Inflammation, Mild Atopic dermatitis, Moderate Atopic dermatitis

Associated Therapies: -

Clinical Trials

Proton Pump Inhibitors Use in Patients With Psoriasis

Phase 4

Withdrawn

Conditions: Psoriasis

Interventions: Drug: esomeprazole
Drug: desonide

First Posted Date: 2015-12-08

Last Posted Date: 2022-08-05

Lead Sponsor: EMS

Registration Number: NCT02624544

Clinical Trial of 4% Niacinamide Versus 0.05% Desonide for the Treatment of Axillar Hyperpigmentation

Phase 4

Completed

Conditions: Hyperpigmentation

Interventions: Drug: Niacinamide
Drug: Placebo
Drug: Desonide

First Posted Date: 2012-03-02

Last Posted Date: 2012-11-29

Lead Sponsor: Universidad Autonoma de San Luis Potosí

Target Recruit Count: 28

Registration Number: NCT01542138

Locations: 🇲🇽
Dermatology Department. Hospital Central "Dr. Ignacio Morones Prieto", San Luis Potosi, Mexico

Prev
1
Next

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy